Utilizing mucin status for instance to predict the risk of disease severity, progression and prognosis would be a valuable tool and the mucus complex further affords potential novel opportunities in the treatment of asthma, CF, non-CF bronchiectasis, and COPD. Here, MUC5AC is linked to chronic obstructive pulmonary disease.